A new trading day began on Tuesday, with Alkermes plc (NASDAQ: ALKS) stock price up 4.31% from the previous day of trading, before settling in for the closing price of $29.72. ALKS’s price has ranged from $25.17 to $36.45 over the past 52 weeks.
Meanwhile, its annual earnings per share averaged -42.69%. With a float of $161.01 million, this company’s outstanding shares have now reached $165.05 million.
Alkermes plc (ALKS) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Alkermes plc is 2.46%, while institutional ownership is 103.01%. The most recent insider transaction that took place on Oct 15 ’25, was worth 283,776. In this transaction EVP R&D, Chief Medical Officer of this company sold 9,000 shares at a rate of $31.53, taking the stock ownership to the 73,740 shares. Before that another transaction happened on Oct 15 ’25, when Company’s Officer proposed sale 9,000 for $31.53, making the entire transaction worth $283,777.
Alkermes plc (ALKS) Recent Fiscal highlights
In its latest quarterly report, released on 12/31/2024, the company reported earnings of 1.05 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.37 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -42.69% per share during the next fiscal year.
Alkermes plc (NASDAQ: ALKS) Trading Performance Indicators
Here are Alkermes plc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.85. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.40. Likewise, its price to free cash flow for the trailing twelve months is 10.66.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 2.08, a number that is poised to hit 0.41 in the next quarter and is forecasted to reach 1.64 in one year’s time.
Technical Analysis of Alkermes plc (ALKS)
Compared to the last year’s volume of 1.85 million, its volume of 3.72 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 28.44%.
During the past 100 days, Alkermes plc’s (ALKS) raw stochastic average was set at 80.65%, which indicates a significant increase from 64.91% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.28 in the past 14 days, which was higher than the 0.92 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $29.48, while its 200-day Moving Average is $30.28. Nevertheless, the first resistance level for the watch stands at $32.18 in the near term. At $33.37, the stock is likely to face the second major resistance level. The third major resistance level sits at $35.25. If the price goes on to break the first support level at $29.11, it is likely to go to the next support level at $27.23. Now, if the price goes above the second support level, the third support stands at $26.04.
Alkermes plc (NASDAQ: ALKS) Key Stats
With a market capitalization of 5.12 billion, the company has a total of 165,078K Shares Outstanding. Currently, annual sales are 1,558 M while annual income is 367,070 K. The company’s previous quarter sales were 390,660 K while its latest quarter income was 87,100 K.
